Immupharma Share Discussion Threads

[andyr42] 19/12/2017 09:28

He has limited vocabulary and in that he can't join the words. Never said anything useful of all the time I've seen this troll. Too cold for riding your BMX remarko?

[spawny100] 19/12/2017 09:18

Nect leg up looking like today perhaps?

[remarkomsoc] 19/12/2017 09:14

Bryan Cranston in Seinfeld was acehttps://www.youtube.com/watch?v=5nz7khqenFU

[longshanks] 19/12/2017 09:09

I personally rate Network with Bryan Cranston, higher

[kensingtoncourt] 19/12/2017 09:02

IMM is one of the best plays on the current market.

[uncleoswald] 19/12/2017 08:56

Oscillating!

[113mike] 19/12/2017 08:54

ha ha...hardly.

[top tips] 19/12/2017 08:46

Morning people. Grabbed a few more. Great times ahead in the new year.

[gbh2] 19/12/2017 08:21

"9 times more buyers than sellers this morning, "

I guess schools finished early in your area, when you grow up you "may" gain some useful insight into trading but until then try and avoid showing off your ignorance every five minutes!

[ny boy] 19/12/2017 08:06

9 times more buyers than sellers this morning, with most obviously holding until the action starts in Q1 - 2018, this will just move higher as stock availability reduces.

[ny boy] 18/12/2017 22:40

Usual pattern, spreads widen, some punters sell and get mugged off before we move another leg higher.

Onwards to 200p+

[adejuk] 18/12/2017 16:07

where are they getting the stock?

[sportbilly1976] 18/12/2017 15:32

The beginning of the next leg up...?

[hamhamham1] 18/12/2017 13:41

If today closes about 164p then its bang on for sitting at the base of the next strong climb (IMHO)

[professor bang bang] 18/12/2017 13:29

Mr McCarthy said previously there would be news on Nucant and Urelix later in 2017, which i took as meaning advancement of trials. The absense of such news could mean IMM are in discussions with someone who wants to buy the whole company, in which case there would be little point in IMM going to the expense of progressing other trials themselves as the buyer would be able to do all that.

[hamhamham1] 18/12/2017 13:23

If the next leg up matches the previous timeframe then it should start rising this Wednesday and last for 2 days. As previous poster earlier said - 7 days consolidating, then 2 days up. Not ramping, just extrapolating the current pattern.

[hottingup] 18/12/2017 11:50

The press release on 25/1/2017 was at 7.00 am GMT. Even if the last patient was somewhere in Europe a couple of hours ahead of Greenwich Mean time, I doubt they would have received their first dose that morning - probably several days beforehand, plus a couple of days to then prepare the Press Release and distribute it via the networks. So as I said earlier, the whole trial probably ends mid Jan 2018 or somewhere in the third week of Jan 2018 at the latest, with last dose 28 days beforehand (this week).

[hamhamham1] 18/12/2017 11:41

hottingup. Thats what my table showed - 13 doses - every 4 weeks - first dose on 25th January 2017 - Thirteenth dose (48 weeks later) on 27th December 2017 ??? right??

[hamhamham1] 18/12/2017 11:39

Active Comparator: IPP-201101 200-mcg plus SOC
Patients randomly assigned to IPP-201101 will be administered a dosage of 200 mcg subcutaneously (sc) every 4 weeks for 48 weeks (a total of 13 doses will be administered).

[hamhamham1] 18/12/2017 11:37

Isn't it every 4 weeks??
hxxps://clinicaltrials.gov/ct2/show/NCT02504645?term=lupuzor&rank=1